Summary
To evaluate the diagnostic and prognostic significance of plasma amino acid imbalance in chronic hepatitis (CH), plasma-free neutral amino acid levels were examined in 47 patients with CH, consisting of 8 chronic persistent hepatitis (CPH), 26 chronic aggressive hepatitis (CAH) 2A and 13 CAH 2B, compared with those of 58 patients with liver cirrhosis (LC) and of 12 healthy controls. Fischer’s ratio (a molar ratio of branched chain amino acids to aromatic amino acids) was found to be reduced in the order of normal subjects (3.5±0.4), CPH (3.0±0.2), CAH2A (2.7±0.3), CAH2B (2.1±0.3), compensated LC (LC-C, 1.5±0.4) and decompensated LC (LC-D, 1.1 ±0.2). Patients with CPH showed a significant decrease of the ratio compared with normal subjects (P<0.05). The ratio was significantly higher in patients with CAH 2B in comparison with LC-C (P<0.001). Especially, the ratio could be used to discriminate the three distinct stages of CH. Discriminant analysis, carried out using six amino acids, Fischer’s ratio and conventional liver function tests indicated that Fischer’s ratio was the most reliable parameter for differentiation of the three stages of CH. Furthermore, serial examinations of Fischer’s ratio in patients with CH remained unchanged in CPH, whereas was significantly reduced in CAH during 2-3 years follow-up. These results strongly suggest that Fischer’s ratio is a useful indicator for differential diagnosis and for prediction of the subsequent clinical course of CH as well as being a sensitive index for functional hepatic reserve in chronic active liver diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Soloway RD, Summerskill WHJ, Archie H, et al: Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenerology 1972;63:820–833
Korman MG, Hofmann AF, Summerskill WHJ: Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology. N Engl J Med 1974;290:1399–1402
Galizzi J, Long RG, Billing BH, et al: Assessment of the14C aminopyrine breath test in liver disease. Gut 1978;19:40–45
Morgan MY, Milson JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phyenylalanine and tyrosine in liver disease. Gut 1978;19:1068–1073
Matsui S: Determination of plasma free amino acids in patients with severe liver damage and its clinical significance. Acta Schol Med Gifu 1979;27:99–130 (in Japanese)
Mccullough AJ, Albert JC, Jones JD, et al: The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease. Gastoenterology 1981;81: 645–652
Takagi Y, Koyama K, Imaoka Y, et al: Plasma amino acid patterns in patients with liver disease. J Jpn Surg Soc 1981;82:1442–1446 (in Japanese)
Morgan MY, Marshall AW, Milson JM, et al: Plasma amino acid patterns in liver disease. Gut 1982;23:362–370
Shiels MT, Czaja AJ, Ludwig J, et al: Diagnostic and prognostic implications of plasma amino acid determinations in chronic active hepatitis. Dig Dis Sci 1985;30:819–823
Fischer JE, Yoshimura N, Aguirre A, et al: Plasma amino acids in patients with hepatic encephalopathy. Effects of amino infusions. Am J Surg 1974;127:40–47
De Groote J, Desmet VJ, Gedick P, et al: A classification of chronic hepatitis. Lancet 1968;II:626–628
Fujikake Y, Sugihara J, Nakamura T, et al: A new rapid and simplified assay of major free amino acids in plasma and its clinical application-Development of the new assay method and its application to differential diagnosis in various diseases of the liver-. Acta Hepat Jap 1981;22:1375–1381 (in Japanese)
Carlisle R, Galambos JT, Warren D: The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci 1979;24:358–362
Czaja AF, Wolf AM, Baggenstoss AH: Laboratory assessment of severe chronic active liver disease during and after corticoid therapy: Correlation of serum transaminase and gamma globulin levels with histologie feasures. Gastroenterology 1981;80: 687–692
Faraj BA, Ali FM, Ansley JD, et al: Decarboxylation to tyramine: an important route of tyrosine metabolism in dogs with experimental hepatic encephalopathy. Gastroenterology 1978;75: 1041–1044
Jagenburg R, Olsson R, Regardh CG, et al: Kinetics of intravenous administered L-phenylalanine in patients with cirrhosis of the liver. Clin Chim Acta 1977;78:453–463
Fischer JE, Rosen HM, Ebeid AM, et al: The effect of normalization of plasma amino acids on hepatic encepalopathy in man. Surgery 1976;80:77–91
Jefferson LS, Rannels DE, Munger BL, et al: Insulin in the regulation of protein turnover in heart and skeletal muscle. Fed Proc 1974;33:1098–1104
Goldberg AL, Chang TW: Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc 1978;37:2301–2307
Hayashi M, Ohnishi H, Kawade Y, et al: Augumented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication. Gastroenterol Jpn 1981;16:64–70
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kano, T., Nagaki, M., Takahashi, T. et al. Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index. Gastroenterol Jpn 26, 344–349 (1991). https://doi.org/10.1007/BF02781923
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02781923